Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Unicycive Therapeutics

UNCY

5.0356.22% ( +0.295 )

Trading: Jul 30, 14:02:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Unicycive Therapeutics (UNCY) Gets a Buy from Maxim Group
Tip Ranks·Jul 14 at 03:25 AM
UNCY+6.22%RANK+3.86%
UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.
MorningStar·Jul 8 at 07:11 PM
UNCY+6.22%
Unicycive Therapeutics posts corporate presentation on kidney disease pipeline, lead hyperphosphatemia drug OLC
PUBT·Jul 6 at 03:04 PM
UNCY+6.22%
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash Position
Tip Ranks·Jul 2 at 09:58 AM
UNCY+6.22%
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
rttnews·Jul 2 at 09:15 AM
NVS-0.79%VRTX-1.54%
Guggenheim Remains a Buy on Unicycive Therapeutics (UNCY)
Tip Ranks·Jul 1 at 05:55 AM
UNCY+6.22%RILY+5.18%
US FDA rejects approval of Unicycive’s kidney disease therapy
Pharmaceutical Business Review·Jul 1 at 05:17 AM
UNCY+6.22%
Unicycive Therapeutics 盘后跌超 10% 受 FDA 就制造缺陷发 CRL 影响
US Stock Market Update·Jun 30 at 06:11 PM
UNCY+6.22%
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga_article·Jun 30 at 04:05 PM
VVOS-0.36%UNCY+6.22%
Unicycive Therapeutics tumbles 8% after hours on FDA complete response letter
US Stock Market Update·Jun 30 at 03:51 PM
UNCY+6.22%
Unicycive says FDA issues CRL for OLC NDA over third-party manufacturing deficiencies
PUBT·Jun 30 at 06:05 AM
UNCY+6.22%
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga_article·Jun 30 at 12:05 PM
CELZ+5.23%VTGN+1.15%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga_article·Jun 30 at 07:05 AM
UPC+6.30%DCOY+4.34%